Micropulse treatment of vitreoretinal pathologies: retrospective and prospective study to collect patient data after subthreshold micropulse treatment

Micropulse treatment of vitreoretinal pathologies: retrospective and prospective study to collect patient data after subthreshold micropulse treatment - -

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023869

Enrollment

100

Registered

2020-12-22

Start date

2019-10-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H35.3

Interventions

Group 1: Patients with untreated intermediate AMD without presence of reticular pseudodrusen. All patients receive a baseline examination with BCVA, lens status, SD-OCT, CF, BAF, OCTA and optional FFA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - untreated patients with a diagnosis of intermediate AMD without the presence of reticular pseudodrusen

Exclusion criteria

Exclusion criteria: - reticular pseudodrusen - severe systematic diseases - turbid refracting media

Design outcomes

Primary

Measure	Time frame
Primary endpoints are: 1) progression to geographic atrophy (GA) by fundus autofluorescence or SD-OCT. 2) Incidence of CNV (choroidal neovascularization).	—

Secondary

Measure	Time frame
Secondary endpoints: 1) BCVA 2) drusen volume	—

Countries

Germany

Contacts

Public ContactNadja Khatami-Kalki

Augenklinik SulzbachKnappschaftsklinikum Saar/Sulzbach

nadja.khatami-kalki@kksaar.de+49 (0)6897 574 1121

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026